1144 MHC II neoantigen vaccines improve antitumor immunity and response to immune checkpoint inhibitor in cold tumor

• Yue Wang,
• Wei Liu,
• Jia Wei,
• Tao Shi,
• Yuting Luo,
• Xueru Song,
• Chun Lu

Affiliations

Yue Wang

2Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China

Wei Liu

1Heinrich Heine University, Dusseldorf, NRW, Germany

Jia Wei

7The Comprehensive Cancer Centre of Drum Tower Hospital, Medi, Nanjing, China

Tao Shi

1The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China., Nanjing, China

Yuting Luo

1The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China., Nanjing, China

Xueru Song

3Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China

Chun Lu

3Model Animal Research Center, Medical School of Nanjing University, Nanjing, Jiangsu, China